Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy

Abstract

The past decades have witnessed the successful transition of several nanotechnology platforms into the clinical trials. However, specific delivery of therapeutics to tumors is hindered by several barriers including cancer recognition and tissue penetration, particle heterogeneity and aggregation, and unfavorable pharmacokinetic profiles such as fast clearance and organ accumulation. With the advent of RNA nanotechnology, a series of RNA nanoparticles have been successfully constructed to overcome many of the aforementioned challenges for in vivo cancer targeting with favorable biodistribution profiles. Compared to other nanodelivery platforms, the physiochemical properties of RNA nanoparticles can be tuned with relative ease for investigating the in vivo behavior of nanoparticles upon systemic injection. The size, shape, and surface chemistry, especially hydrophobic modifications, exert significant impacts on the in vivo fate of RNA nanoparticles. Rationally designed RNA nanoparticles with defined stoichiometry and high homogeneity have been demonstrated to specifically target tumor cells while avoiding accumulation in healthy vital organs after systemic injection. RNA nanoparticles were proven to deliver therapeutics such as siRNA and anti-miRNA to block tumor growth in several animal models. Although the release of anti-miRNA from the RNA nanoparticles has achieved high efficiency of tumor regression in multiple animal models, the efficiency of endosomal escape for siRNA delivery needs further improvement. This review focuses on the advances and perspectives of this promising RNA nanotechnology platform for cancer targeting and therapy.

Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities

“…Different strategies have been developed to ensure endosomal release, one mechanism proposed was the "proton sponge," which are typically polyamines that work by absorbing free protons in the endosomes. Protonable molecules induce an inflow of ions and water into the endosome, subsequently rupturing the endosome and releasing endosome contents into the cell [60]. Another mechanism utilizes an approach modelled on how enveloped viruses induce endosomal escape by fusion of the viral envelope with the endosome membrane, allowing the viral capsid to enter the cytoplasm.…”

Nucleic Acid–Based Functional Nanomaterials as Advanced Cancer Therapeutics

“…RNA‐based materials were fabricated based on both the Watson–Crick and the noncanonical base pairing (such as guanine with adenine or uracil) . Due to their flexible structure, numerous loops and motifs, and a higher thermal stability than DNA‐based materials, RNA‐based materials showed enormous potential as alternative gene therapeutic agents …”

Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation

“…To date, many important barriers (e.g., chemical stability and thermodynamic stability) in the field of RNA nanotechnology have been successfully overcome (Corey, ; Khisamutdinov, Jasinski, & Guo, ; Shu et al, ). The progress in these aspects has been discussed in previous reviews (Jasinski et al, ; Li et al, ; Xu et al, ). Recently, however, more studies have been reported on understanding the broad mechanisms that define the pharmacological and immunological profile of RNA nanoparticles.…”